Sleep and sleep disorders in chronic obstructive pulmonary disease

Respiration

Volumn 80, Issue 1, 2010, Pages 78-86

  Collop, Nancy ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Hypoventilation; Insomnia; Pulmonary function; Sleep disturbances

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; ESZOPICLONE; FLUOXETINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYPNOTIC AGENT; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; MEDROXYPROGESTERONE; RAMELTEON; SALMETEROL; STEROID; TIOTROPIUM BROMIDE; ZOLPIDEM; ZOPICLONE;

AGE; ANXIETY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; DEOXYGENATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPOVENTILATION; INSOMNIA; LUNG FUNCTION; MAJOR DEPRESSION; OXYGEN SATURATION; OXYGEN THERAPY; PRIORITY JOURNAL; REM SLEEP; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; SLEEP DISORDERS;

EID: 77953808045     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258676     Document Type: Review

References (76)

1. Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia AS, McNamara JO, Williams SM: Neuroscience, ed 2. Sunderland, Sinauer, 2001.
2. Mohsenin V: Sleep in chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005; 26: 109-116.
3. Stradling JR, Chadwick GA, Frew AJ: Changes in ventilation and its components in normal subjects during sleep. Thorax 1985; 40: 364-370.
4. West JB: Respiratory Physiology: The Essentials, ed 6. Philadelphia, Lippincott Williams & Wilkins, 2000.
5. DeMarco FJ Jr, Wynne JW, Block AJ, Boysen PG, Taasan VC: Oxygen desaturation during sleep as a determinant of the 'Blue and Bloated' syndrome. Chest 1981; 79: 621-625.
6. Coccagna G, Lugaresi E: Arterial blood gases and pulmonary and systemic arterial pressure during sleep in chronic obstructive pulmonary disease. Sleep 1978; 1: 117-124.
7. Douglas NJ, Calverley PM, Leggett RJ, Brash HM, Flenley DC, Brezinova V: Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet 1979;i:1-4.
8. Koo KW, Sax DS, Snider GL: Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 1975; 58: 663-670.
9. Wynne JW, Block AJ, Hemenway J, Hunt LA, Flick MR: Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am J Med 1979; 66: 573-579.
10. Block AJ, Boysen PG, Wynne JW: The origins of cor pulmonale: a hypothesis. Chest 1979; 75: 109-110.
11. Flenley DC: Clinical hypoxia: causes, consequences, and correction. Lancet 1978; 1: 542-546.
12. Connaughton JJ, Catterall JR, Elton RA, Stradling JR, Douglas NJ: Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease? Am Rev Respir Dis 1988; 138: 341-344.
13. Gay PC: Chronic obstructive pulmonary disease and sleep. Respir Care 2004; 49: 39- 51, discussion 51-52.
14. Heijdra YF, Dekhuijzen PN, van Herwaarden CL, Folgering HT: Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease. Thorax 1995; 50: 610-612.
15. Becker HF, Piper AJ, Flynn WE, McNamara SG, Grunstein RR, Peter JH, Sullivan CE: Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999; 159: 112-118.
16. Phillipson EA: Control of breathing during sleep. Am Rev Respir Dis 1978; 118: 909-939.
17. Douglas NJ: Nocturnal hypoxemia in patients with chronic obstructive pulmonary disease. Clin Chest Med 1992; 13: 523-532.
18. Catterall JR, Calverley PM, MacNee W, Warren PM, Shapiro CM, Douglas NJ, Flenley DC: Mechanism of transient nocturnal hypoxemia in hypoxic chronic bronchitis and emphysema. J Appl Physiol 1985; 59: 1698-1703.
19. Fletcher EC, Gray BA, Levin DC: Nonapneic mechanisms of arterial oxygen desaturation during rapid-eye-movement sleep. J Appl Physiol 1983; 54: 632-639.
20. Ballard RD, Clover CW, Suh BY: Influence of sleep on respiratory function in emphysema. Am J Respir Crit Care Med 1995; 151: 945-951.
21. Mulloy E, McNicholas WT: Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 1996; 109: 387-394.
22. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos Santos J: Sleep-related O 2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J 1997; 10: 1730-1735.
23. Campen MJ, Shimoda LA, O'Donnell CP: Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol 2005; 99: 2028-2035.
24. Moore-Gillon JC, Cameron IR: Right ventricular hypertrophy and polycythaemia in rats after intermittent exposure to hypoxia. Clin Sci (Lond) 1985; 69: 595-599.
25. Weitzenblum E, Chaouat A: Sleep and chronic obstructive pulmonary disease. Sleep Med Rev 2004; 8: 281-294.
26. Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J: Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 2009; 64: 133-138.
27. Lewis CA, Eaton TE, Fergusson W, Whyte KF, Garrett JE, Kolbe J: Home overnight pulse oximetry in patients with COPD: more than one recording may be needed. Chest 2003; 123: 1127-1133.
28. Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, O'Connor GT, Punjabi NM, Shahar E: Sleep and sleepdisordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003; 167: 7-14.
29. Sergi M, Rizzi M, Andreoli A, Pecis M, Bruschi C, Fanfulla F: Are COPD patients with nocturnal REM sleep-related desaturations more prone to developing chronic respiratory failure requiring long-term oxygen therapy? Respiration 2002; 69: 117-122.
30. Catterall JR, Douglas NJ, Calverley PM, Shapiro CM, Brezinova V, Brash HM, Flenley DC: Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis 1983; 128: 24-29.
31. Mulloy E, Fitzpatrick M, Bourke S, O'Regan A, McNicholas WT: Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med 1995; 89: 193-198.
32. McKeon JL, Murree-Allen K, Saunders NA: Prediction of oxygenation during sleep in patients with chronic obstructive lung disease. Thorax 1988; 43: 312-317.
33. Little SA, Elkholy MM, Chalmers GW, Farouk A, Patel KR, Thomson NC: Predictors of nocturnal oxygen desaturation in patients with COPD. Respir Med 1999; 93: 202-207.
34. Zanchet RC, Viegas CA: Nocturnal desaturation: predictors and the effect on sleep patterns in patients with chronic obstructive pulmonary disease and concomitant mild daytime hypoxemia. J Bras Pneumol 2006; 32: 207-212.
35. Flenley DC: Sleep in chronic obstructive lung disease. Clin Chest Med 1985; 6: 651-661.
36. Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R: Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151: 82-86.
37. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J: There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 2005; 72: 142-149.
38. Chaouat A, Weitzenblum E, Krieger J, Sforza E, Hammad H, Oswald M, Kessler R: Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP. Eur Respir J 1999; 13: 1091-1096.
39. Mansfield D, Naughton MT: Effects of continuous positive airway pressure on lung function in patients with chronic obstructive pulmonary disease and sleep disordered breathing. Respirology 1999; 4: 365-370.
40. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980; 93: 391-398.
41. Folgering H: Supplemental oxygen for COPD patients with nocturnal desaturations? Eur Respir J 1999; 14: 997-999.
42. Calverley PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC: The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 1982; 126: 206-210.
43. Goldstein RS, Ramcharan V, Bowes G, Mc- Nicholas WT, Bradley D, Phillipson EA: Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med 1984; 310: 425-429.
44. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation - a consensus conference report. Chest 1999; 116: 521-534.
45. Girault C, Richard JC, Chevron V, Tamion F, Pasquis P, Leroy J, Bonmarchand G: Comparative physiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratory failure. Chest 1997; 111: 1639-1648.
46. Goldstein RS, De Rosie JA, Avendano MA, Dolmage TE: Influence of noninvasive positive pressure ventilation on inspiratory muscles. Chest 1991; 99: 408-415.
47. Windisch W, Storre JH, Sorichter S, Virchow JC Jr: Comparison of volume- and pressurelimited NPPV at night: a prospective randomized cross-over trial. Respir Med 2005; 99: 52-59.
48. Hill NS: Noninvasive ventilation for chronic obstructive pulmonary disease. Respir Care 2004; 49: 72-87, discussion 87-89.
49. Lin CC: Comparison between nocturnal nasal positive pressure ventilation combined with oxygen therapy and oxygen monotherapy in patients with severe COPD. Am J Respir Crit Care Med 1996; 154: 353-358.
50. Clini E, Sturani C, Rossi A, Viaggi S, Corrado A, Donner CF, Ambrosino N: The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-538.
51. Dolly FR, Block AJ: Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Chest 1983; 84: 394-398.
52. Saaresranta T, Aittokallio T, Utriainen K, Polo O: Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease. Respir Res 2005; 6: 28.
53. Daskalopoulou E, Patakas D, Tsara V, Kazis A, Maniki E, Zoglopitis F: Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD). Bull Eur Physiopathol Respir 1987; 23(suppl 11):185s-190s.
54. Gothe B, Cherniack NS, Bachand RT Jr, Szalkowski MB, Bianco KA: Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease. Am J Med 1988; 84: 436-444.
55. Sans-Torres J, Domingo C, Moron A, Rue M, Marin A: Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia. Respir Med 2003; 97: 599-605.
56. Veale D, Cooper BG, Griffiths CJ, Corris PA, Gibson GJ: The effect of controlled-release salbutamol on sleep and nocturnal oxygenation in patients with asthma and chronic obstructive pulmonary disease. Respir Med 1994; 88: 121-124.
57. Campbell M, Eliraz A, Johansson G, Tornling G, Nihlen U, Bengtsson T, Rabe KF: Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respir Med 2005; 99: 1511-1520.
58. Martin RJ, Bartelson BL, Smith P, Hudgel DW, Lewis D, Pohl G, Koker P, Souhrada JF: Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 1999; 115: 1338-1345.
59. McNicholas WT, Calverley PM, Lee A, Edwards JC: Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J 2004; 23: 825-831.
60. Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K: A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. Treat Respir Med 2004; 3: 173-181.
61. Ryan S, Doherty LS, Rock C, Nolan GM, Mc- Nicholas WT: Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. Respiration 2010;79: 475-481.
62. Molfino NA: Drugs in clinical development for chronic obstructive pulmonary disease. Respiration 2005; 72: 105-112.
63. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME: Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006; 47: 312-319.
64. Karajgi B, Rifkin A, Doddi S, Kolli R: The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 1990; 147: 200-201.
65. Yohannes AM, Baldwin RC, Connolly MJ: Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15: 1090-1096.
66. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P: Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67.
67. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006; 59: 1052-1060.
68. Girault C, Muir JF, Mihaltan F, Borderies P, De La Giclais B, Verdure A, Samson-Dollfus D: Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD. Chest 1996; 110: 1203-1211.
69. Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF: Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 1993; 16: 318-326.
70. Muir JF, DeFouilloy C, Broussier P, Locquet R, Maillard F: Comparative study of the effects of zopiclone and placebo on respiratory function in patients with chronic obstructive respiratory insufficiency. Int Clin Psychopharmacol 1990; 5(suppl 2):85-94.
71. Kryger M, Wang-Weigand S, Zhang J, Roth T: Effect of ramelteon, a selective MT(1)/ MT(2)-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep Breath 2008; 12: 243-250.
72. Dolly FR, Block AJ: Increased ventricular ectopy and sleep apnea following ethanol ingestion in COPD patients. Chest 1983; 83: 469-472.
73. Easton PA, West P, Meatherall RC, Brewster JF, Lertzman M, Kryger MH: The effect of excessive ethanol ingestion on sleep in severe chronic obstructive pulmonary disease. Sleep 1987; 10: 224-233.
74. Collop NA, Salas RE, Delayo M, Gamaldo C: Normal sleep and circadian processes. Crit Care Clin 2008; 24: 449-460.
75. Hill NS: Noninvasive ventilation in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21: 783-797.
76. Parmeggiani PL: Physiologic regulation in sleep; in Kryger MH, Roth T, Dement WC (eds): Principles and Practice of Sleep Medicine, ed 4. Philadelphia, Elsevier Health Sciences, 2005.